Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Joseph L Goldstein. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Joseph L Goldstein zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 6 703 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Joseph L Goldstein. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Joseph L Goldstein ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 155 | 6 703 | 2,37 | ||||
| 2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 6 548 | 2,60 | ||||
| 2024-01-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 707 | 6 382 | -29,78 | 950,00 | -2 571 650 | 6 062 900 |
| 2024-01-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 707 | 9 089 | 42,42 | 625,60 | 1 693 499 | 5 686 078 |
| 2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 135 | 6 382 | 2,16 | ||||
| 2023-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3 613 | 6 247 | -36,64 | 800,00 | -2 890 400 | 4 997 600 |
| 2023-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 613 | 9 860 | 57,84 | 482,68 | 1 743 923 | 4 759 225 |
| 2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 165 | 6 247 | 2,71 | ||||
| 2022-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 431 | 0 | -100,00 | |||
| 2022-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 431 | 6 082 | -28,56 | 700,00 | -1 701 700 | 4 257 400 |
| 2022-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 431 | 8 513 | 39,97 | 374,12 | 909 486 | 3 184 884 |
| 2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 2 707 | 2 707 | |||||
| 2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 191 | 6 082 | 3,24 | ||||
| 2021-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 479 | 0 | -100,00 | |||
| 2021-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 479 | 5 891 | -29,62 | 650,00 | -1 611 350 | 3 829 150 |
| 2021-09-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 479 | 8 370 | 42,08 | 380,95 | 944 375 | 3 188 552 |
| 2021-06-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 930 | 2 431 | -44,26 | |||
| 2021-06-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 930 | 5 891 | -24,68 | 525,00 | -1 013 250 | 3 092 775 |
| 2021-06-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 930 | 7 821 | 32,76 | 374,12 | 722 052 | 2 925 993 |
| 2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 3 613 | 3 613 | |||||
| 2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 248 | 5 891 | 4,39 | ||||
| 2020-10-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -9 212 | 0 | -100,00 | |||
| 2020-10-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -9 212 | 5 643 | -62,01 | 600,00 | -5 527 200 | 3 385 800 |
| 2020-10-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 9 212 | 14 855 | 163,25 | 520,01 | 4 790 332 | 7 724 749 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -20 | 5 643 | -0,35 | 552,36 | -11 047 | 3 116 967 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 960 | 2 479 | -66,68 | |||
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -7 830 | 0 | -100,00 | |||
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 784 | 0 | -100,00 | |||
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 530 | 5 663 | -21,27 | 555,74 | -850 282 | 3 147 156 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -899 | 7 193 | -11,11 | 554,82 | -498 783 | 3 990 820 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 101 | 8 092 | -11,98 | 553,17 | -609 040 | 4 476 252 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -513 | 9 193 | -5,29 | 552,01 | -283 181 | 5 074 628 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 501 | 9 706 | -13,39 | 551,09 | -827 186 | 5 348 880 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 600 | 11 207 | -12,49 | 550,11 | -880 176 | 6 165 083 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 600 | 12 807 | -16,88 | 549,07 | -1 427 582 | 7 031 939 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3 654 | 15 407 | -19,17 | 548,13 | -2 002 867 | 8 445 039 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 356 | 19 061 | -6,64 | 547,28 | -742 112 | 10 431 704 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -800 | 20 417 | -3,77 | 546,01 | -436 808 | 11 147 886 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -700 | 21 217 | -3,19 | 544,96 | -381 472 | 11 562 416 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -300 | 21 917 | -1,35 | 543,19 | -162 957 | 11 905 095 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 7 830 | 22 217 | 54,42 | 376,69 | 2 949 483 | 8 368 922 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 4 960 | 14 387 | 52,61 | 380,95 | 1 889 512 | 5 480 728 |
| 2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 784 | 9 427 | 67,06 | 371,40 | 1 405 378 | 3 501 188 |
| 2020-08-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 000 | 5 643 | -15,05 | 617,18 | -617 180 | 3 482 747 | |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 838 | 0 | -100,00 | |||
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 4 838 | -38,28 | |||
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -3 000 | 4 838 | -38,28 | |||
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 6 643 | -2,92 | 604,49 | -120 898 | 4 015 627 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -525 | 6 843 | -7,13 | 603,82 | -317 006 | 4 131 940 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 196 | 7 368 | -13,97 | 602,70 | -720 829 | 4 440 694 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -400 | 8 564 | -4,46 | 601,29 | -240 516 | 5 149 448 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 8 964 | -2,18 | 600,12 | -120 024 | 5 379 476 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 9 164 | -2,14 | 598,07 | -119 614 | 5 480 713 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -771 | 9 364 | -7,61 | 597,51 | -460 680 | 5 595 084 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 111 | 10 135 | -9,88 | 596,47 | -662 678 | 6 045 223 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -700 | 11 246 | -5,86 | 595,31 | -416 717 | 6 694 856 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -60 | 11 946 | -0,50 | 592,46 | -35 548 | 7 077 527 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 12 006 | -0,83 | 590,47 | -59 047 | 7 089 183 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 12 106 | -1,63 | 589,87 | -117 974 | 7 140 966 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -3 200 | 12 306 | -20,64 | 587,88 | -1 881 216 | 7 234 451 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -300 | 15 506 | -1,90 | 587,20 | -176 160 | 9 105 123 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 15 806 | -1,25 | 585,58 | -117 116 | 9 255 677 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 175 | 16 006 | -6,84 | 583,67 | -685 812 | 9 342 222 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 17 181 | -1,15 | 582,31 | -116 462 | 10 004 668 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 17 381 | -0,57 | 580,65 | -58 065 | 10 092 278 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 4 838 | 17 481 | 38,27 | 413,33 | 1 999 691 | 7 225 422 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 000 | 12 643 | 31,11 | 413,33 | 1 239 990 | 5 225 731 |
| 2020-06-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 000 | 12 643 | 31,11 | 413,33 | 1 239 990 | 5 225 731 |
| 2020-06-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 000 | 6 643 | -13,08 | 578,94 | -578 940 | 3 845 898 | |
| 2020-05-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 000 | 7 643 | -20,74 | 560,00 | -1 120 000 | 4 280 080 | |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 0 | -100,00 | |||
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -300 | 9 643 | -3,02 | 482,82 | -144 846 | 4 655 833 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -500 | 9 943 | -4,79 | 479,21 | -239 605 | 4 764 785 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 10 443 | -1,88 | 476,16 | -95 232 | 4 972 539 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -327 | 10 643 | -2,98 | 475,31 | -155 426 | 5 058 724 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -73 | 10 970 | -0,66 | 474,88 | -34 666 | 5 209 434 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 11 043 | -0,90 | 471,34 | -47 134 | 5 205 008 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 11 143 | -1,76 | 470,83 | -94 166 | 5 246 459 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -100 | 11 343 | -0,87 | 469,80 | -46 980 | 5 328 941 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -200 | 11 443 | -1,72 | 468,14 | -93 628 | 5 356 926 |
| 2020-03-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 11 643 | 20,74 | 33,42 | 66 840 | 389 109 |
| 2020-02-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 000 | 9 643 | -9,40 | 382,83 | -382 830 | 3 691 630 | |
| 2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 4 361 | 4 361 | |||||
| 2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 320 | 10 643 | 3,10 | ||||
| 2019-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 2 000 | -33,33 | |||
| 2019-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 000 | 10 323 | -8,83 | 370,00 | -370 000 | 3 819 510 |
| 2019-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 000 | 11 323 | 9,69 | 33,42 | 33 420 | 378 415 |
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 3 000 | -25,00 | |||
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 000 | 10 323 | -8,83 | 360,00 | -360 000 | 3 716 280 |
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 000 | 11 323 | 9,69 | 33,42 | 33 420 | 378 415 |
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 4 000 | -20,00 | |||
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 000 | 10 323 | -8,83 | 350,00 | -350 000 | 3 613 050 |
| 2019-11-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 000 | 11 323 | 9,69 | 33,42 | 33 420 | 378 415 |
| 2019-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 000 | 10 323 | -8,83 | 340,44 | -340 440 | 3 514 362 | |
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 11 323 | -8,11 | 305,93 | -305 930 | 3 464 045 | |
| 2019-01-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 791 | 0 | -100,00 | |||
| 2019-01-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 791 | 12 323 | -12,69 | 410,00 | -734 310 | 5 052 430 |
| 2019-01-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 791 | 14 114 | 14,53 | 273,67 | 490 143 | 3 862 578 |
| 2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 784 | 3 784 | |||||
| 2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
A - Award | 323 | 12 323 | 2,69 | ||||
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -709 | 1 791 | -28,36 | |||
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -709 | 12 000 | -5,58 | 410,00 | -290 690 | 4 920 000 |
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 709 | 12 709 | 5,91 | 273,67 | 194 032 | 3 478 072 |
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 2 500 | -44,44 | |||
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 400,00 | -800 000 | 4 800 000 |
| 2018-10-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 273,67 | 547 340 | 3 831 380 |
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 4 500 | -18,18 | |||
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 4 500 | -18,18 | |||
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 12 000 | -7,69 | 387,29 | -387 290 | 4 647 480 |
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 000 | 8,33 | 273,67 | 273 670 | 3 557 710 |
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 13 000 | 8,33 | 273,67 | 273 670 | 3 557 710 |
| 2018-09-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 12 000 | -7,69 | 390,00 | -390 000 | 4 680 000 |
| 2018-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 0 | -100,00 | |||
| 2018-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 380,00 | -760 000 | 4 560 000 |
| 2018-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 57,11 | 114 220 | 799 540 |
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 2 000 | -50,00 | |||
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 370,00 | -740 000 | 4 440 000 |
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 57,11 | 114 220 | 799 540 |
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 4 000 | -33,33 | |||
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 360,00 | -720 000 | 4 320 000 |
| 2018-07-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 57,11 | 114 220 | 799 540 |
| 2018-03-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 6 000 | -25,00 | |||
| 2018-03-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 350,02 | -700 040 | 4 200 240 |
| 2018-03-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 57,11 | 114 220 | 799 540 |
| 2018-03-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 8 000 | -20,00 | |||
| 2018-03-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 12 000 | -14,29 | 340,00 | -680 000 | 4 080 000 |
| 2018-03-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 14 000 | 16,67 | 57,11 | 114 220 | 799 540 |
| 2018-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 12 000 | -7,69 | 325,60 | -325 600 | 3 907 200 | |
| 2018-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 439 | 7 439 | |||||
| 2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 6 500 | -13,33 | |||
| 2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 13 000 | -7,14 | 500,01 | -500 010 | 6 500 130 |
| 2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 14 000 | 7,69 | 273,67 | 273 670 | 3 831 380 |
| 2017-06-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 7 500 | -11,76 | |||
| 2017-06-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 13 000 | -7,14 | 482,55 | -482 550 | 6 273 150 |
| 2017-06-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 14 000 | 7,69 | 273,67 | 273 670 | 3 831 380 |
| 2017-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 830 | 7 830 | |||||
| 2016-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 125 | 8 500 | -20,00 | |||
| 2016-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 125 | 13 000 | -14,05 | 450,00 | -956 250 | 5 850 000 |
| 2016-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 125 | 15 125 | 16,35 | 273,67 | 581 549 | 4 139 259 |
| 2016-08-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 125 | 10 625 | -16,67 | |||
| 2016-08-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 125 | 13 000 | -14,05 | 425,00 | -903 125 | 5 525 000 |
| 2016-08-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 125 | 15 125 | 16,35 | 273,67 | 581 549 | 4 139 259 |
| 2016-04-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -1 000 | 0 | -100,00 | |||
| 2016-04-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 13 000 | -7,14 | 425,00 | -425 000 | 5 525 000 |
| 2016-04-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 13 000 | -7,14 | 425,00 | -425 000 | 5 525 000 |
| 2016-04-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 14 000 | 7,69 | 177,82 | 177 820 | 2 489 480 |
| 2016-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 1 000 | -66,67 | |||
| 2016-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 14 000 | -12,50 | 400,00 | -800 000 | 5 600 000 |
| 2016-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 16 000 | 14,29 | 177,82 | 355 640 | 2 845 120 |
| 2016-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 000 | 3 000 | -40,00 | |||
| 2016-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 14 000 | -12,50 | 375,00 | -750 000 | 5 250 000 |
| 2016-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 16 000 | 14,29 | 177,82 | 355 640 | 2 845 120 |
| 2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 9 212 | 9 212 | |||||
| 2015-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 14 000 | -12,50 | 586,00 | -1 172 000 | 8 204 000 |
| 2015-07-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 16 000 | -11,11 | 550,00 | -1 100 000 | 8 800 000 |
| 2015-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 18 000 | -10,00 | 526,85 | -1 053 700 | 9 483 300 |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 20 000 | -9,09 | 514,81 | -1 029 620 | 10 296 200 | |
| 2015-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 22 000 | -8,33 | 513,74 | -1 027 480 | 11 302 280 | |
| 2015-05-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | -20 000 | 0 | -100,00 | ||||
| 2015-05-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 20 000 | 24 000 | 500,00 | ||||
| 2015-02-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -5 000 | 5 000 | -50,00 | ||||
| 2015-02-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -4 600 | 4 000 | -53,49 | 423,61 | -1 948 606 | 1 694 440 | |
| 2015-02-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -400 | 8 600 | -4,44 | 424,14 | -169 656 | 3 647 604 | |
| 2015-02-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 9 000 | 125,00 | 177,82 | 889 100 | 1 600 380 | |
| 2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 838 | 10 838 | |||||
| 2014-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -5 000 | 10 000 | -33,33 | ||||
| 2014-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -5 000 | 4 000 | -55,56 | 398,31 | -1 991 550 | 1 593 240 | |
| 2014-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 9 000 | 125,00 | 177,82 | 889 100 | 1 600 380 | |
| 2014-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 4 000 | -33,33 | 350,31 | -700 620 | 1 401 240 | |
| 2014-08-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 6 000 | -25,00 | 347,65 | -695 300 | 2 085 900 | |
| 2014-08-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 8 000 | -20,00 | 331,20 | -662 400 | 2 649 600 | |
| 2014-03-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | -10 000 | 20 000 | -33,33 | ||||
| 2014-03-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 10 000 | 10 000 | |||||
| 2014-02-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 0 | -100,00 | 338,86 | -338 860 | ||
| 2014-02-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 1 000 | -45,95 | 326,96 | -277 916 | 326 960 | |
| 2014-02-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -100 | 1 850 | -5,13 | 327,14 | -32 714 | 605 209 | |
| 2014-02-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -50 | 1 950 | -2,50 | 327,17 | -16 358 | 637 982 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 2 000 | -33,33 | 320,62 | -320 620 | 641 240 | |
| 2014-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 750 | 12 750 | |||||
| 2013-11-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 3 000 | -25,00 | 300,74 | -300 740 | 902 220 | |
| 2013-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 4 000 | -20,00 | 238,29 | -238 290 | 953 160 | |
| 2013-08-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | -5 000 | 30 000 | -14,29 | ||||
| 2013-08-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 5 000 | 5 000 | |||||
| 2013-05-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -4 000 | 0 | -100,00 | 252,20 | -1 008 800 | ||
| 2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | -4 000 | 35 000 | -10,26 | ||||
| 2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 4 000 | 4 000 | |||||
| 2013-04-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 0 | -100,00 | |||
| 2013-04-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 0 | -100,00 | 180,00 | -900 000 | |
| 2013-04-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 24,41 | 122 050 | 122 050 | |
| 2013-01-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 10 000 | -33,33 | |||
| 2013-01-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 0 | -100,00 | 185,00 | -925 000 | |
| 2013-01-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 57,11 | 285 550 | 285 550 | |
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 740 | 5 000 | -35,40 | |||
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -2 260 | 7 740 | -22,60 | |||
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 740 | 0 | -100,00 | 180,50 | -494 570 | |
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 740 | 2 740 | 33,42 | 91 571 | 91 571 | |
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 260 | 0 | -100,00 | 181,22 | -409 557 | |
| 2013-01-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 260 | 2 260 | 33,42 | 75 529 | 75 529 | |
| 2013-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2012-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 0 | -100,00 | |||
| 2012-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 0 | -100,00 | 120,00 | -600 000 | |
| 2012-03-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 18,61 | 93 050 | 93 050 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 5 000 | -50,00 | |||
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -400 | 10 000 | -3,85 | |||
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 600 | 10 400 | -30,67 | |||
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 0 | -100,00 | 115,00 | -575 000 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 18,61 | 93 050 | 93 050 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 0 | -100,00 | 111,06 | -44 424 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 400 | 400 | 18,61 | 7 444 | 7 444 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 600 | 0 | -100,00 | 110,77 | -509 542 | |
| 2012-03-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 600 | 4 600 | 18,61 | 85 606 | 85 606 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -5 000 | 10 000 | -33,33 | |||
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -10 000 | 5 000 | -66,67 | |||
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 0 | -100,00 | 110,02 | -1 100 200 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 24,41 | 244 100 | 244 100 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 000 | 0 | -100,00 | 110,02 | -550 100 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 33,42 | 167 100 | 167 100 | |
| 2012-01-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -10 000 | 0 | -100,00 | 80,00 | -800 000 | |
| 2012-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
| 2008-08-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | -3 000 | 49 000 | -5,77 | ||||
| 2008-08-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 3 000 | 3 000 |